We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+18.49%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
AUM
$1.78B
AUM Growth
+$242M
Cap. Flow
-$5.15M
Cap. Flow %
-0.29%
Top 10 Hldgs %
52.41%
Holding
310
New
14
Increased
56
Reduced
56
Closed
5

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$44.9M
2
WST icon
West Pharmaceutical
WST
+$3.89M
3
ROK icon
Rockwell Automation
ROK
+$3.51M
4
ADBE icon
Adobe
ADBE
+$3.37M
5
AAPL icon
Apple
AAPL
+$2.92M

Top Sells

Rank Stock Value
1
EL icon
Estee Lauder
EL
+$37M
2
NVDA icon
NVIDIA
NVDA
+$9M
3
AMZN icon
Amazon
AMZN
+$6.64M
4
EPAM icon
EPAM Systems
EPAM
+$6.47M
5
PSA icon
Public Storage
PSA
+$5.33M

Sector Composition

Rank Sector Weight
1 Technology 43.49%
2 Healthcare 15.9%
3 Consumer Discretionary 13.64%
4 Communication Services 9.44%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEY icon
301
KeyCorp
KEY
$24.2B
$11.9K ﹤0.01%
1,291
COIN icon
302
Coinbase
COIN
$38.6B
$10.7K ﹤0.01%
150
OGN icon
303
Organon & Co
OGN
$3.56B
$9.18K ﹤0.01%
441
APA icon
304
APA Corp
APA
$13.2B
$7.79K ﹤0.01%
228
ALL icon
305
Allstate
ALL
$68B
$7.47K ﹤0.01%
68
CF icon
306
CF Industries
CF
$19.2B
-26,494
Closed -$1.92M
DG icon
307
Dollar General
DG
$28B
-5,024
Closed -$1.06M
EL icon
308
Estee Lauder
EL
$30.4B
-150,294
Closed -$37M
EPAM icon
309
EPAM Systems
EPAM
$5.51B
-21,627
Closed -$6.47M
VRNS icon
310
Varonis Systems
VRNS
$4.59B
-66,629
Closed -$1.73M

Similar funds

Silvant Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Silvant Capital Management held 310 positions worth $1.78B, up 16% from $1.54B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Silvant Capital Management's Q2 2023 filing shows 14 new, 56 increased, 56 reduced and 5 closed positions. Its largest new stake was West Pharmaceutical: 10,893 shares worth $4.17M. The largest sale was Estee Lauder, an estimated $37M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Silvant Capital Management's largest Q2 2023 buy was West Pharmaceutical: 10,893 shares worth $4.17M.
  • Silvant Capital Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $44.9M increase.
  • Silvant Capital Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $9M.
  • Silvant Capital Management fully exited Estee Lauder in Q2 2023, selling an estimated $37M.
  • Silvant Capital Management's ten largest holdings make up 52% of its $1.78B portfolio in Q2 2023.
  • Silvant Capital Management opened 14 new positions and closed 5 in Q2 2023.
  • Silvant Capital Management's portfolio value rose 16% quarter-over-quarter to $1.78B.

Based on Silvant Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.